Benzinga | Dec 15, 2020 12:19PM EST

Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $227

Morgan Stanley maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $230 to $227.